Latest News and Press Releases
Want to stay updated on the latest news?
-
1 October 2021 - 30 September 2022 Coloplast delivered Q4 organic growth of 5% and 30% EBIT margin before special items Coloplast delivered 5% organic growth in Q4....
-
Årsregnskabsmeddelelse 2021/22 1. oktober 2021 – 30. september 2022 Coloplast leverede 5% organisk vækst og en overskudsgrad før særlige poster på 30% i 4. kvartal. Coloplast leverede en...
-
Coloplast is introducing the Saffron™ Fixation System designed for ease and reliability during pelvic floor reconstruction for women who suffer from pelvic organ prolapse (POP). “Our goal...
-
Please see enclosed pdf. Attachment 14092022_trading_in_shares_ASL ...
-
Se venligst vedlagte pdf. Vedhæftet fil 14092022_handel_med_aktier_ASL ...
-
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ ...
-
Venligst se vedlagte pdf. For yderligere information og kalenderinvitationer til kommende begivenheder, besøg...
-
31 August 2022 Coloplast is hosting a Meet the Management event in Humlebæk, Denmark, today at 11:30 CEST, where the company will provide a progress update on its Strive25 strategy. The event will...
-
31. August Coloplast afholder mød ledelsen arrangement i Humlebæk i dag kl. 11.30, hvor virksomhedens ledelse vil give en statusopdatering på Strive25-strategien. Arrangementet starter med et...
-
9M 2021/22 Interim financial results, 9M 2021/22 1 October 2021 - 30 June 2022 Coloplast delivered Q3 organic growth of 8% and an EBIT margin of 30%. Unchanged financial guidance for FY...